Basic and Diluted Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2019

Schedule of Common Equivalent Shares were Excluded From Diluted Net Loss Per Share Calculation because their Inclusion would have been Anti-Dilutive

The following common equivalent shares were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive:

	As of September 30,
	2019		2018
Stock options		797,848		1,836,671
Convertible senior notes		3,411,199		3,411,199
Non-vested performance-based restricted stock units		594,723		93,362
Non-vested market-based restricted stock units		—		11,877
Non-vested restricted stock units		650,093		417,209
Total		5,453,863		5,770,318

Schedule of Common Stock Reserved

The amount of such shares of the Company’s common stock reserved for these purposes at September 30, 2019 is as follows:

	Number of Shares
Stock options issued and outstanding		797,848
Additional shares available for grant under equity plans		2,394,561
Total		3,192,409